Area of Interest COVID-19

COVID-19 Update

Standard BioTools Research and Response to the COVID-19 Pandemic

Standard BioTools™ supports the response to the global COVID-19 pandemic with technologies that enable research and applications for SARS-CoV-2 virus detection and the monitoring of human immune system response to infection and COVID-19 disease. To that end, our technologies are well-positioned for use in providing a robust public research response in support of policies and treatments aligned with local, state and national recovery.

Technology & Research

COVID-19 Disease Immune Monitoring and Spatial Tissue Profiling Research

Standard BioTools CyTOF® technology with the Maxpar® Direct™ Immune Profiling Assay™ provide best-in-class immune monitoring with the cost, flexibility and consistency needed for standardized COVID-1...

COVID-19 Disease Therapeutic and Vaccine Development

Both CyTOF technology with the Maxpar Direct Immune Profiling Assay and Imaging Mass Cytometry™ enable immune response studies designed to identify prognostic and mechanistic biomarkers that can be us...

Proven performance

Maxpar Direct Immune Profiling System

Learn more about the Maxpar Direct Immune Profiling Assay and Maxpar Pathsetter™ software, the first complete sample-to-answer solution for high-dimensional immune profiling of human PBMC and whole blood, with proven performance in multi-site studies.

Read the recent paper reporting results from the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study, a longitudinal, multi-site study that used the Maxpar Direct Immune Profiling Assay as a key assay in its multi-omic workflow.


Learn more

Get more information

Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.